Cancer/Tumors Clinical Trials

A listing of Cancer/Tumors medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

MMG
Duarte California 91010

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
La Jolla California 92093

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Loma Linda California 92350

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Stanford California 94305

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Florida

Jupiter Medical Center
Jupiter Florida 33458

Procurement of Human Biospecimens for Research

Jupiter Medical Center
Jupiter Florida 33458

Procurement of Human Biospecimens for Research

Georgia

Memorial University Medical Center
Savannah Georgia 31404

Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754) Versus Placebo in Patients With Progressive Carcinoid Tumors

Memorial University Medical Center
Savannah Georgia 31404

National Oncologic PET Registry (NOPR)

New Jersey

Mirati Research Site
Hackensack New Jersey

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

New York

Mirati Research Site
Bronx New York 10461

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

MMG
Bronx New York 10467

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Oregon

MMG
Portland Oregon 97225

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Pennsylvania

MMG
Hershey Pennsylvania 17033

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

MMG
Philadelphia Pennsylvania 19111

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

South Carolina

MMG
Charleston South Carolina 29425

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Tennessee

MMG
Nashville Tennessee 37232

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Texas

Mirati Research Site
Dallas Texas 75201

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

Virginia

MMG
Charlottesville Virginia 22908

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Washington

Mirati Research Site
Seattle Washington 98109

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

West Virginia

MMG
Morgantown West Virginia 26506

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.

Wisconsin

MMG
Madison Wisconsin 53706

Finding the right ALK+ lung cancer treatment is your top priority. It’s our top priority too.